Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Happiness Development Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products. The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand.
No reported earnings periods on file.
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $71.5M | $20.8M | $0.00 | $0.00 | $71,542.00 |
| Gross profit | $18.2M | $257,260.00 | $0.00 | $0.00 | $9,016.00 |
| Operating income | $1.5M | -$11.2M | -$4.0M | -$4.3M | -$6.8M |
| Net income | $786,356.00 | -$48.8M | -$71.7M | -$10.1M | -$7.9M |
| Diluted EPS | $0.03 | -$1.22 | -$12.63 | — | — |
| Operating cash flow | $2.9M | -$10.5M | -$20.7M | -$13.1M | -$2.7M |
| Free cash flow | $121,026.00 | -$10.8M | -$20.7M | -$13.1M | — |
| Gross margin | 25.4% | 1.2% | — | — | 12.6% |
| Operating margin | 2.1% | -53.8% | — | — | -9481.9% |
| Net margin | 1.1% | -235.1% | — | — | -11033.0% |
No quarterly data.
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.